In small cell lung cancer (SCLC) targeting the IGF-IR using the monoclonal antibody NVP-ADW742 sensitizes SCLC cell lines to the effects of etoposide and carboplatin [79]. The gene discussed is IGF1R; the disease is small cell lung carcinoma.